Reactivation of Latent Granulomatous Infections by Infliximab
Open Access
- 1 August 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (Supplement) , S194-S198
- https://doi.org/10.1086/429996
Abstract
Although infliximab and etanercept share tumor necrosis factor (TNF) as a common therapeutic target, accumulating data indicate that infliximab (an aKeywords
This publication has 27 references indexed in Scilit:
- Granulomatous Infections Due to Tumor Necrosis Factor Blockade: CorrectionClinical Infectious Diseases, 2004
- Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in MiceThe Journal of Experimental Medicine, 2004
- Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonistsArthritis & Rheumatism, 2004
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor AntagonistsClinical Infectious Diseases, 2004
- TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial InfectionThe Journal of Immunology, 2002
- Estimation of the Annual Risk of Tuberculous Infection for White Men in the United StatesThe Journal of Infectious Diseases, 1997
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Mycobacterium tuberculosis (MTB)- stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTBTubercle and Lung Disease, 1997
- Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot.Proceedings of the National Academy of Sciences, 1990
- Lymphocyte subsets in granulomas of human tuberculosis: An in situ immunofluorescence study using monoclonal antibodiesPathology, 1990